BSE filing, NSE: ORCHPHARMA. Summary written from the filing by ALFA Finder's alert engine.
Orchid Pharma Ltd: key numbers
- Share price
- ₹891.00
- Market cap
- ₹5,336 Cr
- Revenue (annual)
- ₹811.3 Cr
- Net profit (annual)
- ₹20.55 Cr
- P/E (TTM)
- 615.6×Sector 46.1×
- Promoter holding
- 74.45%+4.61% QoQ
- FII holding
- 0.93%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Orchid Pharma Ltd
All →Orchid Pharma Partnership
Orchid Pharma entered a licensing and supply agreement with Laboratorio Libra for Exblifep across nine Latin American markets. The partnership is expected to represent a potential opportunity of about USD 80 million over 10 years.
Orchid Pharma Fund Raise of ₹600 Cr
Orchid Pharma's board approved an enabling resolution to raise funds of up to ₹600 Crore through equity or debt securities via various permissible modes.
- Value
- ₹600.0 Cr
Orchid Pharma Other Announcement
The company submitted its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026.
Orchid Pharma Board Meeting Date
Orchid Pharma has scheduled a board meeting for October 20, 2026, to consider options for raising funds. The company will explore various suitable funding avenues.
Orchid Pharma Annual General Meeting
Orchid Pharma held its 33rd Annual General Meeting on September 29, 2026, where shareholders considered and approved routine business resolutions and related party transactions.
Orchid Pharma Capital Structure Change
Orchid Pharma Limited received trading approval for 4,45,86,052 equity shares issued under its NCLT-sanctioned scheme of amalgamation, effective September 23, 2026.
Other other announcement announcements
All →Parth Electricals & Engineering Other Announcement
Parth Electricals filed its fifth Monitoring Agency Report for the quarter ended September 30, 2026. It confirms no deviation from the issue objects.
KHFM Hospitality & Facility Management Services Other Announcement
KHFM filed a non-applicability notice for the Corporate Governance Report for the quarter ended 30 September 2026, with a practising CS certificate. This is routine compliance paperwork with no business or financial event.
Motilal Oswal Financial Services Other Announcement
Motilal Oswal Financial Services certifies utilisation of proceeds from listed Commercial Papers issued in the quarter ended September 30, 2026, and adherence to listing conditions. This is a periodic regulatory compliance certificate.
Invigorated Business Consulting Other Announcement
Invigorated Business Consulting appointed GAV & Associates as statutory auditor from 1 April 2027 for 60 months. The routine appointment carries no financial impact.
- Execution
- 60 months from 1 April 2027
Boss Packaging Solutions Other Announcement
Boss Packaging Solutions Limited states that Regulation 27 corporate governance provisions do not apply to it for the quarter ended 30 September 2026, as an SME-listed company. This is a compliance non-applicability intimation with no business event.
Apar Industries Other Announcement
APAR Industries' QIP monitoring agency reported no fund deviation for the quarter ended September 30, 2026. Utilisation matches the offer document, with ₹560.14 crore unutilised.